Sorger Lab

Harvard Medical School

Home
People
Publications
Contact

Latest News

FamPlex: A Resource for Entity Recognition and Relationship Resolution of Human Protein Families and Complexes in Biomedical Text Mining June 28, 2018
Encoding Growth Factor Identity in the Temporal Dynamics of FOXO3 under the Combinatorial Control of ERK and AKT Kinases May 31, 2018
A High Content Screen in Macrophages Identifies Small Molecule Modulators of STING-IRF3 and NFkB Signaling March 19, 2018
Inflammatory but not Mitogenic Contexts Prime Synovial Fibroblasts for Compensatory Signaling Responses to p38 Inhibition March 6, 2018
Multiplexed Immunofluorescence Reveals Potential PD-1/PD-L1 Pathway Vulnerabilities in Craniopharyngioma March 2, 2018
Small-Molecule Screen Identifies De Novo Nucleotide Synthesis as a Vulnerability of Cells Lacking SIRT3 February 20, 2018
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy December 14, 2017
The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations November 24, 2017
From Word Models to Executable Models of Signaling Networks Using Automated Assembly November 24, 2017
Quantification of sensitivity and resistance of breast cancer cell lines to anti-cancer drugs using GR metrics November 7, 2017

« Peter Sorger to speak at German Symposium on Systems Biology 2009

Video: For cancer cells, genetics alone is poor indicator for drug response »

Medill Reports: Drug’s effect on cancer cells may impact tumor treatment

Original article.

April 22nd, 2009 | Category: Lab In The News |

Comments are closed.

Harvard

Harvard Medical School
Harvard Program in Therapeutic Science
Laboratory of Systems Pharmacology
Systems Biology Dept.

Tools

DataRail
GR Calculator
INDRA
PySB
RNAseq Pipeline

Lab

Login
HMS OMERO Server

Copyright © 2025 President and Fellows of Harvard College
Powered by WordPress & Atahualpa